BGB-11417-301
The main objective of this study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia (CLL)
Discover New Possibilities: Find Your Path to Healing through Valkyrie Clinical Trials